242 related articles for article (PubMed ID: 32393965)
1. Multimodality imaging in cardiac amyloidosis: a primer for cardiologists.
Jurcuţ R; Onciul S; Adam R; Stan C; Coriu D; Rapezzi C; Popescu BA
Eur Heart J Cardiovasc Imaging; 2020 Aug; 21(8):833-844. PubMed ID: 32393965
[TBL] [Abstract][Full Text] [Related]
2. Multimodality imaging in cardiac amyloidosis: State-of-the-art review.
Timóteo AT; Rosa SA; Brás PG; Ferreira MJV; Bettencourt N
J Clin Ultrasound; 2022 Oct; 50(8):1084-1096. PubMed ID: 36218201
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic imaging of cardiac amyloidosis.
Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
[TBL] [Abstract][Full Text] [Related]
4. Detection and Diagnosis of Cardiac Amyloidosis in Egypt.
Abdelghany M; Abdelhamid M; Allam A; El Etriby A; Hafez S; Ragy H; Sobhy M
Cardiol Ther; 2023 Mar; 12(1):197-213. PubMed ID: 36611101
[TBL] [Abstract][Full Text] [Related]
5. Multimodality Imaging in Cardiac Amyloidosis.
Giblin GT; Cuddy SAM
Curr Cardiol Rep; 2021 Aug; 23(10):134. PubMed ID: 34410523
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.
Korosoglou G; Giusca S; André F; Aus dem Siepen F; Nunninger P; Kristen AV; Frey N
Vasc Health Risk Manag; 2021; 17():661-673. PubMed ID: 34720583
[TBL] [Abstract][Full Text] [Related]
7. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
[TBL] [Abstract][Full Text] [Related]
8. Detection of cardiac amyloidosis with
Kircher M; Ihne S; Brumberg J; Morbach C; Knop S; Kortüm KM; Störk S; Buck AK; Reiter T; Bauer WR; Lapa C
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1407-1416. PubMed ID: 30798427
[TBL] [Abstract][Full Text] [Related]
9. Multimodality imaging approach to cardiac amyloidosis: part 2.
Sennott J; Ananthasubramaniam K
Heart Fail Rev; 2022 Sep; 27(5):1515-1530. PubMed ID: 34694574
[TBL] [Abstract][Full Text] [Related]
10. Monitoring cardiac amyloidosis with multimodality imaging.
Starr N; Ioannou A; Martinez-Naharro A
Rev Esp Cardiol (Engl Ed); 2024 Jan; 77(1):79-87. PubMed ID: 37696332
[TBL] [Abstract][Full Text] [Related]
11. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
12.
Saad JM; Ahmed AI; Han Y; Saeed S; Pournazari P; Al-Mallah MH
Heart Fail Rev; 2022 Sep; 27(5):1493-1503. PubMed ID: 34709500
[TBL] [Abstract][Full Text] [Related]
13. Cardiac amyloidosis: A survey of current awareness, diagnostic modalities, treatment practices, and clinical challenges among cardiologists in selected Middle Eastern countries.
Mohty D; Nasr S; Ragy H; Farhan HA; Fadel B; Alayary I; Ghoubar M
Clin Cardiol; 2023 Jun; 46(6):648-655. PubMed ID: 37038634
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
Brownrigg J; Lorenzini M; Lumley M; Elliott P
ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.
Jung MH; Chang S; Han EJ; Youn JC
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloidosis: Recent advances in the diagnosis and therapy.
Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB
Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995
[TBL] [Abstract][Full Text] [Related]
18. [Ten questions for the cardiologist about cardiac scintigraphy with bone tracers, amyloidosis and the heart].
Porcari A; Rossi M; Dore F; Imazio M; Fontana M; Merlo M; Sinagra G
G Ital Cardiol (Rome); 2022 Jun; 23(6):424-432. PubMed ID: 35674032
[TBL] [Abstract][Full Text] [Related]
19. Extracardiac soft tissue uptake, evidenced on early
Malka N; Abulizi M; Kharoubi M; Oghina S; Galat A; Le Bras F; Moktefi A; Guendouz S; Molinier-Frenkel V; Fanen P; Funalot B; Lefaucheur JP; Blanc-Durand P; Deux JF; Audard V; Bodez D; Itti E; Damy T
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2396-2406. PubMed ID: 32157431
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
